Inventor · disambiguated record
Brian Edward Collins
Also filed as: COLLINS BRIAN · COLLINS BRIAN E · COLLINS BRIAN EDWARD
16 granted patents·24 pending applications·168 citations·filing 1995–2020
93Inventor score
Files withMOMENTA PHARMACEUTICALS INC26COLLINS BRIAN EDWARD4BULIK DOROTA A1COLLINS BRIAN E1GALLOWAY NIALL1
Top patents by PatentIndex Score
40 records- 0189US9890410B2N-acetylhexosamine-containing N-glycans in glycoprotein productsMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·7 cites·34 claims
- 0288US9677105B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jun 13, 2017·7 cites·24 claims
- 0388US8361705B2Characterization of N-glycans using exoglycosidasesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jan 29, 2013·14 cites·13 claims
- 0485US8338088B2Methods related to cell surface glycosylationCOLLINS BRIAN EDWARD·Filed 2008·Granted Dec 25, 2012·14 cites·22 claims
- 0583US9170249B2N-acetylhexosamine-containing N-glycans in glycoprotein productsWASHBURN NATHANIEL J·Filed 2012·Granted Oct 27, 2015·10 cites·26 claims
- 0683US8357671B2High affinity Siglec ligandsPAULSON JAMES·Filed 2006·Granted Jan 22, 2013·14 cites·52 claims
- 0777US9921210B2High mannose glycansCOLLINS BRIAN EDWARD·Filed 2011·Granted Mar 20, 2018·2 cites·12 claims
- 0876US6274568B1Compounds for altering cell surface sialic acids and methods of use thereforFiled 1999·Granted Aug 14, 2001·66 cites·19 claims
- 0970US10450361B2Methods related to CTLA4-Fc fusion proteinsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Oct 22, 2019·2 cites·20 claims
- 1069US9029081B2Characterization of N-glycans using exoglycosidasesMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted May 12, 2015·1 cites·28 claims
- 1167US5653011AFixture for replacing a bearingFiled 1995·Granted Aug 5, 1997·27 cites·1 claims
- 1264US9650433B2Modified glycoproteinsBULIK DOROTA A·Filed 2012·Granted May 16, 2017·1 cites·14 claims
- 1360US9061121B2Targeting therapeutic agentsGALLOWAY NIALL·Filed 2010·Granted Jun 23, 2015·3 cites·58 claims
- 1460US2020109432A1Analysis of Disulfide BondsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1559US2019079101A1Methods of evaluating and making biologicsMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1658US2020354465A1Methods Related to AlemtuzumabMOMENTA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1757US10377809B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 13, 2019·0 cites·13 claims
- 1857US2010113294A1Defined glycoprotein products and related methodsMOMENTA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1956US2010151499A1Proteolytic release of glycansMOMENTA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2055US2015158943A1Methods related to adalimumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2155US2015204884A1Methods of evaluating and making biologicsMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2253US2010051887A1Wire strainerROBERTSON ENG LTD·Filed 2009·Application pending·0 cites
- 2353US2019077857A1Methods related to adalimumabMOMENTA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2452US2015125848A1Methods related to alemtuzumabMOMOENT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2552US2012264927A1Methods for labeling glycansPARSONS IAN CHRISTOPHER·Filed 2008·Application pending·0 cites
- 2651US2017233782A1Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2750US2016097074A1Defined glycoprotein products and related methodsMOMENTA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2848US9695244B2Methods related to denosumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jul 4, 2017·0 cites·20 claims
- 2945US2015152184A1Methods related to panitumumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3044US2015104444A1Methods related to trastuzumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3144US2015147317A1Methods related to bevacizumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3244US2015140608A1Methods related to omalizumabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3344US2015141620A1Methods related to rituximabMOMENTA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3443US2015275266A1Analysis of disulfide bondsMOMENTA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3543US2013123126A1Selection and use of host cells for production of glycoproteinsCOLLINS BRIAN EDWARD·Filed 2011·Application pending·0 cites
- 3640US2011213137A1Isotopically-labeled glycansMOMENTA PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3739US10266590B2Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Apr 23, 2019·0 cites·15 claims
- 3838US2017152319A1Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3935US2012277165A1Methods of modulating fucosylation of glycoproteinsCOLLINS BRIAN E·Filed 2010·Application pending·0 cites
- 4031US2012329709A1Production of glycoproteinsCOLLINS BRIAN EDWARD·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →